Medicare approves WashU Medicine’s whole-genome test for blood cancers

ChromoSeq is the name of a new test for two blood cancers - a test developed by a team at Washington University School of Medicine in St. Louis. ChromoSeq is the first whole-genome sequencing test for cancer to be approved for reimbursement by the Centers for Medicare & Medicaid Services. For more information, see here: medicine.wustl.edu/news/medic...
Video by Katie Gertler/Washington University School of Medicine in St. Louis